KPTI•benzinga•
Karyopharm Expects 2025 Sales Of $140M-$155M Versus Consensus Of $160.55M, With US Xpovio Net Product Revenue Expected To Be $115M-$130M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 19, 2025 by benzinga